Mounjaro (Tirzepatide)
What makes tirzepatide different from other GLP-1 medicines, and what a course of treatment involves.
Mounjaro is tirzepatide — the newest of the three GLP-1 medicines we work with, and structurally different from the other two. Here is what that difference actually means for you.
What it is
| Active ingredient | Manufacturer | Class | Administration |
|---|---|---|---|
| Tirzepatide | Eli Lilly | Dual GIP/GLP-1 receptor agonist | Once-weekly injection |
- 01Dual receptor actionActs on both GLP-1 and GIP receptors, rather than GLP-1 alone — the defining difference from Wegovy and Ozempic.
- 02Appetite regulationReduces hunger and cravings through the same fullness-signalling pathway as other GLP-1 medicines.
- 03Blood sugar and metabolic effectsThe added GIP action is associated with further improvements in blood sugar control for many patients.
A different mechanism, not just a different brandThe second receptor is why tirzepatide is often associated with a stronger average effect — though individual response always varies.How dosing typically progresses
Treatment starts at the lowest available strength and rises in stages roughly a month apart, only if the current dose is well tolerated. Your prescriber sets the actual schedule against your response.
- Assessment and eligibility review before any prescription
- Starting dose kept low specifically to reduce early side effects
- Increases held, raised or reduced at every monthly review
- Nutrition and resistance training built in to protect muscle as weight falls
Side effects
The pattern mirrors other GLP-1 medicines — nausea, reduced appetite, constipation and occasional reflux, most noticeable around each dose increase. Some patients notice effects slightly earlier in the dose range than with single-receptor medicines, though this varies considerably.
Medicines are not interchangeable
Switching between tirzepatide and semaglutide is a clinical decision, not a straightforward substitution — doses do not translate directly between them.
Who should not take it
Any one of these needs to be discussed openly before treatment starts — some rule it out, others simply need specialist input first.
- Personal or family history of medullary thyroid carcinoma, or MEN2 syndrome
- Previous pancreatitis, or active gallbladder disease
- Pregnancy, planned pregnancy, or breastfeeding
- Severe gastrointestinal disease, including gastroparesis
- A current or past eating disorder, without specialist input first
If you take insulin or a sulfonylurea, those doses usually need reducing to avoid low blood sugar. Bring a complete list of your medications and supplements to your assessment.
Mounjaro (Tirzepatide) ExplainedWhat makes the dual-receptor mechanism different, and how dosing typically progresses.
Is Mounjaro right for you?
That is a five-minute conversation, not a guess. Book an assessment or ask us first.
Mounjaro, answered
Is Mounjaro stronger than Wegovy or Ozempic?
It acts on an additional receptor and is often associated with a greater average effect in trials, but individual response varies — "stronger" does not mean "right for you" without assessment.
How often is it injected?
Once weekly, on the same day each week, with or without food.
What if I miss a dose?
There is a window within which a missed dose can still be taken safely — ask your prescriber for the specific guidance rather than guessing.
Can I switch from Ozempic to Mounjaro?
This is a clinical decision based on your response and history, not a simple swap. Discuss it at a follow-up rather than switching independently.
How long do people typically stay on it?
It varies. Some continue long term, others taper with a maintenance plan — reviewed at every follow-up, not decided once.
Does The Prime Fit prescribe Mounjaro directly?
Eligibility and prescribing are confirmed at a medical consultation. We do not sell or dispense medication online.